我要投票 枫橡在医疗保健行业中的票数:342
· 外 推 电 报 ·
2025-08-05 09:03:35 星期二

【枫橡是哪个国家的品牌?】

枫橡是什么牌子?「枫橡」是 沈阳枫橡医疗美容咨询有限公司 旗下著名品牌。该品牌发源于辽宁沈阳,由创始人陶林帅在2017年12月19日期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力枫橡品牌出海!将品牌入驻外推网,定制枫橡品牌推广信息,可以显著提高枫橡产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

企业简介

►枫橡国际——大连医院

作为枫橡健康管理有限公司东北区两大转化基地的大连枫橡健康中心,位于“北方明珠”大连滨海中路100号,占地7000余平方米,它为亚健康人群打造集系统化检测、解读生命密码、干细胞技术、免疫力提升、休闲度假五维一体的多功能健康服务平台。

现有健康服务人员500余人,拥有由院士专家工作站及细胞医学领域国内外知名科学家和专业技术精英构成的国内顶尖技术研发团队。吸引了来自美国/加拿大/德国/英国/日本等 地约30位海归学者。30%以上的博士学历。

►枫橡国际——沈阳医院

沈阳医院中心院区位于盛京八门之一怀远门(辽宁影视大厦)。建筑面积10000平方米,总投资额一亿三千万人民币。内部包含有整形美容科、干细胞体验中心、生殖抗衰中心、皮肤高保养、光电皮肤科。作为全球医疗技术交流中心,沈阳枫橡拥有东北首台ACT自体血液干细胞的制备技术,光电皮肤科设备总价值超过2000万。

企业理念

怀揣医者之心,回归医疗本质

企业定位

同步国际一流健康理念,引力健康新“枫橡”

文化属性

释放自我,尊重生命,用艺术打造生命的医疗,生命艺术,塑造精彩。

企业承诺

只采用安全先进的国际医疗技术,只选择国际权威专家,只制定可靠有效的健康方案。

企业愿景

成为国际领先的健康服务机构,全面提高国民健康水平和生活质量,做好中国诚信医疗,全球优质健康美业医疗服务商。

企业历程

Face X起源于1998年,在美国洛杉矶举办的国际美容整形外科学会(ISAPA)大会上,由杜克大学医学院、哈佛大学医学院共同提出建设医疗健康全球一体化理念,并结合美国哈佛大学经济学教授马丁·魏茨曼 《共享经济》学说,从此一种新型的医疗模式孕育而生。

2000年,美国杜克大学Regeneration Next(再生下一代)科学机构细胞研究中心成立。

2003年,杜克大学Regeneration Next(再生下一代)科学机构首次对人类胚胎干细胞完成了基因工程操作,在干细胞医疗研究应用上前进了一大步,干细胞实验技术获得临床应用认证,在美国北卡罗来纳州小范围进行推广。

2005年4月,杜克大学和新加坡国立大学签署了正式协议,两所机构成为合作伙伴,在新加坡设立了杜克—新加坡国立大学医学院以及一批有尖端专项科研的机构。其中包括:国家癌症中心,国家心脏中心,全国眼科中心,国家神经科学研究所、Regeneration Next(再生下一代)项目研究。

回国后,Chris 博士以敏锐的医学洞察力,发现干细胞应用在国内市场处于空白状态,为了改善国民体质,提高国民健康生活质量,于同年6月在香港成立枫橡健康管理有限公司。

2015年,枫橡集团陆续在华北地区(北京)、华南地区(深圳)、东北地区(沈阳)、华中地区(武汉)、西南地区(重庆)、华东地区(杭州)成立六大事业部。全国推广枫橡健康理念,推动全球医疗健康一体化。

2017年,枫橡健康已发展成为集医疗整形机构、精准皮肤高保养机构、细胞医学技术研发中心、国际抗衰疗养院等14家直属机构的医疗健康管理集团,业务覆盖韩国、马来西亚、泰国、日本、印度尼西亚、香港、澳门、台湾、中国大陆等 11 个国家和地区。将世界顶级先进医疗技术和健康项目以最快速度覆盖推广,为所有人群提供精准细胞抗衰老及健康咨询服务。

2018年,枫橡国际与北京京蒙高科干细胞技术有限公司达成战略合作,于6月正式签订合同协议,在全国范围内共同推广及应用干细胞科学技术,共同建设京蒙×枫橡国际医疗技术交流中心。

特色项目

专利技术:毛刺疗法.会呼吸的针

博恩种鼻术:不开刀.不手术.打造完美立体的翘鼻

肌肉复位术:让松弛下垂肌肉恢复到原有的位置

脂肪管理:瘦素细胞.加速脂肪代谢.抑制脂肪新生

医疗团队

►团队理念与宗旨

“美,可供给你光彩、喜悦、富足的生活所需要的一切。但千枝万叶,都是自己的一部分,我们要通过领先的医美科技,为爱美女性延缓衰老,即使需要通过手术,我们也拒绝流水线式的生产“网红面孔”,让每一位客户“美的自然,美的灵动,美的没有痕迹”,这也是我们的美学设计师们和我们的明星医生团队一致的追求,也是我们重新定义的美学。”

英文翻译:Company profile ► Fengxiang International - Dalian Fengxiang health center, as the two transformation bases of Fengxiang Health Management Co., Ltd. in the northeast, is located at No. 100, Binhai Middle Road, Dalian, the "Pearl of the north", covering an area of more than 7000 square meters. It creates a multi-dimensional system for sub-health people, including systematic detection, interpretation of life code, stem cell technology, immune enhancement, leisure and vacation Functional health service platform. At present, there are more than 500 health service personnel, with the top domestic technology research and development team composed of academician expert workstation and domestic and foreign well-known scientists and professional technical elites in the field of cell medicine. It has attracted about 30 returned scholars from the United States / Canada / Germany / Britain / Japan and other places. More than 30% doctoral degree. The central hospital area of Shenyang hospital of Fengxiang international Shenyang hospital is located in Huaiyuanmen (Liaoning film and television building), one of the eight gates of Shengjing. The construction area is 10000 square meters, with a total investment of 130 million yuan. The interior includes plastic and beauty department, stem cell experience center, reproductive anti-aging center, skin high maintenance, photoelectric dermatology. As a global medical technology exchange center, Shenyang Fengxiang has the first act blood stem cell preparation technology in Northeast China, with a total value of more than 20 million optoelectronic dermatology equipment. The enterprise concept carries the heart of the doctor, returns to the positioning of the medical essence enterprise and synchronizes with the world-class health concept. It focuses on the new "Fengxiang" cultural attribute of health to release itself, respects life, creates the medical and life art of life with art, and creates excellence. The enterprise promises to only adopt safe and advanced international medical technology, only select international authoritative experts, and only formulate reliable and effective health programs. The vision of the company is to become a leading international health service organization, comprehensively improve the national health level and quality of life, do a good job in China's honest medical service, and become a global high-quality health and beauty medical service provider. The business process of facex originated in 1998. At the isapa conference held in Los Angeles, the United States, Duke University School of medicine and Harvard University School of Medicine jointly proposed the concept of building a global integration of medical health, and combined with Martin Weitzman, Professor of economics at Harvard University, the theory of sharing economy, from then on a new medical model was born. In 2000, the cell research center of the regeneration next scientific institution of Duke University was established. In 2003, the regeneration next Science Institute of Duke University completed the genetic engineering operation of human embryonic stem cells for the first time, and made a big step forward in stem cell medical research and application. The stem cell experimental technology obtained the clinical application certification, and was popularized in a small scale in North Carolina, USA. In April 2005, Duke University and National University of Singapore signed a formal agreement, and the two institutions became partners. Duke National University of Singapore Medical School and a number of institutions with cutting-edge special research were established in Singapore. Including: National Cancer Center, National Heart Center, National Eye Center, National Institute of neuroscience, regeneration next project research. After returning home, Dr. Chris, with keen medical insight, found that the application of stem cells in the domestic market was in a blank state. In order to improve the national physique and improve the national healthy life quality, he established Fengxiang Health Management Co., Ltd. in Hong Kong in June of the same year. In 2015, Fengxiang group successively established six business divisions in North China (Beijing), South China (Shenzhen), Northeast China (Shenyang), central China (Wuhan), Southwest China (Chongqing) and East China (Hangzhou). Promote Fengxiang health concept nationwide and promote the integration of global health care. In 2017, Fengxiang health has developed into a medical and health management group with 14 directly affiliated institutions including medical plastic institutions, precision skin high maintenance institutions, research and development center of cell medicine technology, international anti-aging sanatorium, covering 11 countries and regions including South Korea, Malaysia, Thailand, Japan, Indonesia, Hong Kong, Macao, Taiwan and Mainland China. We will promote the world's top medical technology and health projects with the fastest speed, and provide accurate cell anti-aging and health consulting services for all people. In 2018, Fengxiang international reached strategic cooperation with Beijing Jingmeng high tech Stem Cell Technology Co., Ltd. and formally signed a contract agreement in June to jointly promote and apply stem cell science and technology nationwide and jointly build Jingmeng × Fengxiang international medical technology exchange center. Special project patent technology: burr therapy, breathing needle born rhinoplasty: no operation, no operation, perfect three-dimensional nose lifting muscle reduction: let loose and sagging muscles return to the original position fat Management: leptin cells, accelerate fat metabolism, inhibit fat newborn medical team ► team concept and purpose "beauty, can provide you with the needs of glorious, joyful and rich life Everything. But thousands of branches and thousands of leaves are part of our own. We need to use leading medical technology to delay the aging of beauty lovers. Even if we need to operate, we also refuse to produce "net red face" by assembly line, so that every customer "beauty is natural, beauty is flexible and beauty has no trace". This is also the same as our aesthetic designers and our star doctor team Pursuit is also our redefinition of aesthetics. "

本文链接: https://www.waitui.com/brand/1df40d4d7.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

改革加速,多家农信社省级机构招兵买马

截至目前,河南、内蒙古等地的农村信用社省级机构已挂牌营业,国内由农信改革而生的新省级机构达到了10家。改革发展向来离不开人才。近期,浙江、辽宁、海南、江西等地的多家农村信用社省级机构均发布了社会招聘公告,招纳总行高管、金融科技、公司金融等相关人才。业内人士指出,各地农村信用社省级机构陆续筹备落地,经营状态也将从“挂牌运营”走向“完善治理”,相应的人才队伍特别是金融科技人才急需补充和储备,以来提升差异化服务、数字化风控等能力,预计未来市场化招聘高管也将成为新趋势。(证券时报)

2小时前

国债等债券利息收入8日起恢复征收增值税,机构称对券商业绩影响较小

根据日前财政部、国家税务总局发布的《关于国债等债券利息收入增值税政策的公告》,自2025年8月8日起,对在该日期之后(含当日)新发行的国债、地方政府债券、金融债券的利息收入,恢复征收增值税。在机构人士看来,增值税采用“新老划段”方式恢复征收,对于券商自营业务的影响可控,要关注券商自营业务配置的股债再平衡趋势,以及券商板块业绩和估值修复。(中证网)

2小时前

人形机器人“订单潮”涌动,表演、导览仍是“主战场”

近期多位头部选手不约而同地斩获了大单,前有智元机器人、宇树科技“分食”总预算1.24亿元的人形双足机器人代工服务采购项目,后有优必选中标总预算9051.15万元的机器人设备采购项目。总体上看,上述订单的主要应用场景为表演讲解、展馆导览等交互服务领域。业内认为,从高关注度、低技术门槛的表演导览场景切入,是新技术推广的普遍规律和务实选择,也是后续拓展至工业制造及家庭服务场景的必要基础和起点。当前人形机器人产业所展现的“订单潮”,正是这条漫长产业征途上落下的一串脚印。(上证报)

2小时前

华泰证券:看好价值重估逻辑下的商业地产板块

36氪获悉,华泰证券研报表示看好价值重估逻辑下的商业地产板块:头部运营商购物中心资产均超越账面投资性房地产公允价值,而更为关键的是,C-REITs通道使得这一价值的实现路径更为通畅,流动性增厚使得这一估值更具有参考意义。在商业地产着重布局的开发类企业以及具备运营管理溢价的物管标的都面临发展机遇。

2小时前

A股半年报前瞻:高比例分红成亮点

A股半年报陆续披露。Wind数据显示,截至8月4日18时,A股共有87家上市公司对外披露2025年半年报,其中58家上市公司实现归属于上市公司股东的净利润同比增长。从利润分配角度看,目前,已有30家上市公司发布半年报的同时,对外发布2025年半年度利润分配预案,不少公司拟派发现金红利比例较高。(中证报)

2小时前

本页详细列出关于枫橡的品牌信息,含品牌所属公司介绍,枫橡所处行业的品牌地位及优势。
咨询